Virtual Investor Event
Join Hansa Biopharma for an investor event featuring KOLs David R. Cornblath, MD (Johns Hopkins University), and Simon Rinaldi, MRCP(Neuro), PhD (University of Oxford), discussing unmet need and current treatment landscape for Guillain-Barré syndrome (GBS).
June 16, 14:00 CEST/8:00 AM ET
Register and attendOn 28 September 2022 Hansa Biopharma joined the William Blair KOL Expert event Innovations in Organ Transplant. Here you can access the recording for the two Hansa-related presentations.
Keynote presentation by Dr. Orio Bestard, head of the Nephrology and Kidney Transplantation Department at Vall d’Hebron University Hospital, Barcellona, Spain.
This recording is password protected. Please use the following password to access the recordings: wbkol9.28
Presentation by Christian Kjellman, CSO/COO at Hansa Biopharma.
This recording is password protected. Please use the following password to access the recordings: wbkol9.28